GSK 625433

Drug Profile

GSK 625433

Alternative Names: 625433; GSK625433

Latest Information Update: 03 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antivirals; Pyrazoles; Pyrrolidines; Thiazoles
  • Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 31 Dec 2008 Discontinued - Phase-I for Hepatitis C in USA (unspecified route)
  • 18 Apr 2007 Clinical data presented at the 223rd American Chemical Society National Meeting (ACS-2007) added to the pharmacokinetics section
  • 31 Oct 2006 Phase-I clinical trials in Hepatitis C in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top